Patient Square Capital LP
MENLO PARK, CA · CIK 1819257 · 13F filing filed 2026-08-12
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Others nearbyAtherton, CA
As an employer
US visa salary filings
- Filings FY20252
- Median salary offered$188,750
- Middle half$176,875 – $200,625
- Job titles2
| Job title | Filings | Median |
|---|---|---|
| Deal Professional AssociateMenlo Park, CA | 1 | $212,500 |
| Private Equity AssociateMenlo Park, CA | 1 | $165,000 |
Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: Patient Square Capital LP.
$645.5m
reported value
+14.5% vs Q1 2026
23positions
80.1%in top 10
6 new
9 added
8 reduced
12 sold out
vs Q1 2026
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ROIVANT SCIENCES LTD ROIV | $283.9m43.97% | Reduced -145.1k |
| REVOLUTION MEDICINES INC RVMD | $51.7m8.01% | New |
| MIRUM PHARMACEUTICALS INC MIRM | $30.5m4.72% | Added +30.5k |
| ABIVAX SA ABVX | $27.5m4.26% | Added +85.3k |
| BEIGENE LTD ONC | $25.7m3.97% | Added +9.5k |
| PHARVARIS N V PHVS | $23.2m3.60% | Added +178.2k |
| ARGENX SE ARGX | $21.3m3.31% | Reduced -13.7k |
| UNITED THERAPEUTICS CORP DEL UTHR | $20.1m3.12% | New |
| BELITE BIO INC BLTE | $16.9m2.62% | Reduced -6.7k |
| COGENT BIOSCIENCES INC COGT | $16.4m2.55% | Reduced -171.0k |
| DBV TECHNOLOGIES S A DBVT | $14.9m2.31% | Added +215.9k |
| XENON PHARMACEUTICALS INC XENE | $13.3m2.06% | Reduced -7.0k |
| BIONTECH SE BNTX | $12.5m1.94% | New |
| ARCUS BIOSCIENCES INC RCUS | $11.0m1.70% | Added +160.8k |
| ENLIVEN THERAPEUTICS INC ELVN | $10.8m1.67% | Added +12.5k |
| DIANTHUS THERAPEUTICS INC DNTH | $10.5m1.63% | Added +14.1k |
| ALLOGENE THERAPEUTICS INC ALLO | $10.5m1.63% | Added +1.6m |
| EYEPOINT PHARMACEUTICALS INC EYPT | $10.3m1.59% | Reduced -75.0k |
| ARCUTIS BIOTHERAPEUTICS INC ARQT | $9.7m1.50% | Reduced -30.6k |
| C4 THERAPEUTICS INC CCCC | $7.5m1.16% | New |
| INVENTIVA SA IVA | $7.4m1.15% | New |
| KYMERA THERAPEUTICS INC KYMR | $5.4m0.84% | Reduced -52.5k |
| FAETH THERAPEUTICS INC FTH | $4.4m0.68% | New |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| INSMED INC INSM | $25.8m157.5k shares |
| LEGEND BIOTECH CORP LEGN | $17.9m990.0k shares |
| NEKTAR THERAPEUTICS NKTR | $15.1m210.0k shares |
| CELCUITY INC CELC | $10.8m95.0k shares |
| MERCK & CO INC MRK | $9.6m80.0k shares |
| PERSPECTIVE THERAPEUTICS INC CATX | $6.8m1.6m shares |
| DEFINIUM THERAPEUTICS INC DFTX | $6.3m331.0k shares |
| HARROW INC HROW | $5.8m165.2k shares |
| PROTARA THERAPEUTICS INC TARA | $5.4m1.0m shares |
| CYTOMX THERAPEUTICS INC CTMX | $5.1m1.1m shares |
| ASSEMBLY BIOSCIENCES INC ASMB | $3.8m136.3k shares |
| SPYRE THERAPEUTICS INC SYRE | $50.4k1.0k shares |